BC

Boxer Capital Portfolio holdings

AUM $2.04B
This Quarter Return
+38.03%
1 Year Return
+108.35%
3 Year Return
+260.95%
5 Year Return
+1,103.68%
10 Year Return
–
AUM
$439M
AUM Growth
+$439M
Cap. Flow
-$41.2M
Cap. Flow %
-9.37%
Top 10 Hldgs %
79.78%
Holding
32
New
6
Increased
4
Reduced
9
Closed
2

Top Buys

1
ZGNX
Zogenix, Inc.
ZGNX
$7.01M
2
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$6.22M
3
ONCT
Oncternal Therapeutics, Inc. Common Stock
ONCT
$4.77M
4
CBAY
Cymabay Therapeutics
CBAY
$4.74M
5
KURA icon
Kura Oncology
KURA
$4.66M

Top Sells

1
ESPR icon
Esperion Therapeutics
ESPR
$25.1M
2
INCY icon
Incyte
INCY
$12.6M
3
MDCO
Medicines Co
MDCO
$11.7M
4
PTCT icon
PTC Therapeutics
PTCT
$9M
5
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
$7.84M

Sector Composition

1 Healthcare 91.24%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
AVXS
1
DELISTED
AveXis, Inc. Common Stock
AVXS
$77.4M 17.62% 800,000 – –
ONC
2
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
$62.1M 14.13% 600,000 – –
CLVS
3
DELISTED
Clovis Oncology, Inc.
CLVS
$41.2M 9.38% 500,000 – –
MGNX icon
4
MacroGenics
MGNX
$112M
$40.7M 9.26% 2,200,000 +85,000 +4% +$1.57M
MDCO
5
DELISTED
Medicines Co
MDCO
$33.3M 7.59% 900,000 -315,000 -26% -$11.7M
ESPR icon
6
Esperion Therapeutics
ESPR
$448M
$25.1M 5.71% 500,000 -500,000 -50% -$25.1M
PTCT icon
7
PTC Therapeutics
PTCT
$3.92B
$25M 5.69% 1,250,000 -450,000 -26% -$9M
BPMC
8
DELISTED
Blueprint Medicines
BPMC
$17.4M 3.97% 250,000 – –
GTHX
9
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$15.7M 3.57% 629,179 – –
KURA icon
10
Kura Oncology
KURA
$686M
$12.6M 2.88% 844,789 +311,538 +58% +$4.66M
MRTX
11
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$12.1M 2.76% 1,037,994 – –
PBYI icon
12
Puma Biotechnology
PBYI
$254M
$12M 2.73% 100,000 – –
LJPC
13
DELISTED
La Jolla Pharmaceutical Company
LJPC
$9.3M 2.12% 267,500 – –
CBAY
14
DELISTED
Cymabay Therapeutics
CBAY
$8.17M 1.86% 1,012,986 +587,986 +138% +$4.74M
ZGNX
15
DELISTED
Zogenix, Inc.
ZGNX
$7.01M 1.6% +200,000 New +$7.01M
RETA
16
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$6.22M 1.42% +200,000 New +$6.22M
SBBP
17
DELISTED
Strongbridge Biopharma plc.
SBBP
$5.91M 1.35% 856,900 -83,100 -9% -$573K
ONCT
18
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$4.77M 1.09% +565,291 New +$4.77M
NGNE icon
19
Neurogene
NGNE
$264M
$4.43M 1.01% 312,500 -212,500 -40% -$3.02M
SIOX
20
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$3.44M 0.78% +500,000 New +$3.44M
RGLS
21
DELISTED
Regulus Therapeutics
RGLS
$2.75M 0.63% +2,197,802 New +$2.75M
BLPH
22
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
$2.64M 0.6% 1,857,143 – –
ARDM
23
DELISTED
Aradigm Corp Common Stock
ARDM
$2.1M 0.48% +500,000 New +$2.1M
VIRX
24
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$1.99M 0.45% 1,025,000 – –
VXX
25
DELISTED
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
$1.96M 0.45% 50,000 -200,000 -80% -$7.84M
1
2